Prediction of caspase-3 inhibitory activity of 1,3-dioxo-4-methyl-2,3-dihydro-1h-pyrrolo[3,4-c] quinolines: QSAR study

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 23, Issue 3, 2008, Pages 424-431

  Sharma, Simant ^a   Ravichandran, V ^a   Jain, Prateek ^a   Mourya, V K ^b   Agrawal, R K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

1,3 dioxo 4 methyl 2; 3 dihydro 1H pyrrolo 3,4 c quinolines; Caspases 3; Inhibition; QSAR

Indexed keywords

1,3 DIOXO 4 METHYL 2,3 DIHYDRO 1H PYRROLO[3,4 C]QUINOLINE DERIVATIVE; CASPASE 3; QUINOLINE DERIVATIVE;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONFORMATION; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; IC 50; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; VALIDATION PROCESS;

CASPASE 3; DRUG DESIGN; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOLINES;

EID: 46649101520     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360701652476     Document Type: Article

References (19)

1. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C. and Hammond, J. (1999) Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and alzheimer's disease. J Biol Chem, 13, pp. 23426-23436.
2. Wellington, C. and Hayden, M. (2000) Caspases and neurodegeneration: On the cutting edge of new therapeutic approaches. Clin Genet, 57, pp. 1-10.
3. Han, BH, Xu, D., Choi, J., Han, Y., Xanthoudakis, S., Roy, S., Tam, J., Vaillancourt, J., Colucci, J., Siman, R., Giroux, A., Robertson, GS, Zamboni, R. and Holtzman, DM (2002) Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem, 277, pp. 30128-30136.
4. Haunstetter, A. and Izumo, S. (1998) Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res, 82, pp. 1111-1129.
5. Hoglen, NC, Chen, LS, Fisher, CD, Hirakawa, BP, Groessl, T. and Contreras, PC (2004) Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]- propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro- phenoxy)- pentanoic acid): A liver-targeted caspase inhibitor. J Pharmacol Exp Ther, 309, pp. 634-640.
6. Jacobson, MD (1998) Anti-apoptosis therapy: A way of treating neural degeneration?. Curr Biol, 8, pp. 418-421.
7. Thornberry, NA and Lazebnik, Y. (1998) Caspases: Enemies within. Science, 281, pp. 1312-1316.
8. Marques, CA, Keil, U., Bonert, A., Steiner, B., Haass, C., Muller, WE and Eckert, A. (2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked swedish amyloid precursor protein mutation: Oxidative stress, caspases, and the JNK pathway. J Biol Chem, 278, pp. 28294-28302.
9. Scott, CW, Sobotka-Briner, C., Wilkins, DE, Jacobs, RT, Folmer, JJ, Frazee, WJ, Bhat, RV, Ghanekar, SV and Aharony, D. (2003) Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis. J Pharmacol Exp Ther, 304, pp. 433-440.
10. Webber, SE, Tikhe, J., Worland, ST, Fuhrman, SA, Hendrickson, TF, Matthews, DA, Love, RA, Patick, AK, Meador, JW, Ferre, RA, Brown, EL, DeLisle, DM, Ford, CE and Binford, SL (1996) Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J Med Chem, 39, pp. 5072-5082.
11. Webber, SE, Okano, K., Little, TL, Reich, SH, Xin, Y., Fuhrman, SA, Matthews, DA, Love, RA, Hendrickson, TF, Patick, AK, Meador, JW, Ferre, RA, Brown, EL, Ford, CE, Binford, SL and Worland, ST (1998) Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: Design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. J Med Chem, 41, pp. 2786-2805.
12. Wang, QM, Johnson, RB, Jungheim, LN, Cohen, JD and Villarreal, EC (1998) Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicrob Agents Chemother, 42, pp. 916-920.
13. 1a-Adrenoceptor antagonists. Indian J Pharm Sci, 65, pp. 586-590.
14. Ravichandran, V. and Agrawal, RK (2007) Predicting anti-HIV activity of PETT derivatives: CoMFA approach. Bioorg Med Chem Lett, 17, pp. 2197-2202.
15. Sahu, KK, Ravichandran, V., Mourya, VK and Agrawal, RK (2007) QSAR analysis of caffeoyl naphthalene sulphonamide derivatives as HIV-1 Integrase inhibitors. Med Chem Res
16. Jain, HK and Agrawal, RK (2006) QSAR analysis of Indomethacin derivatives as selective COX-2 inhibitors. Inter Elect J Mol Design, 5, pp. 224-226.
17. Jain, HK and Agrawal, RK (2007) Topological descriptors in modeling tumor necrosis factor alpha inhibitory activity of xanthines, pteridinediones and related compounds. Inter Elect J Mol Design
18. Jain, HK, Mourya, VK and Agrawal, RK (2006) Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses. Bioorg Med Chem Lett, 16, pp. 5280-5284.
19. Kravchenko, DV, Kysil, VV, Ilyn, AP, Tkachenko, SE, Maliarchouk, S., Okun, IM and Ivachtchenko, AV (2005) 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors. Bioorg Med Chem Lett, 15, pp. 1841-1845.